Smoking Cessation & Nicotine De-addiction Market Research Report

1
Smoking Cessation Nicotine De-Addiction Market
Size, Share Trends Analysis Report and Segment
Forecast, 2024 Grand View Research, Inc
The global Smoking Cessation And Nicotine
De-Addiction Market is expected to reach over USD
21.8 billion by 2024 according to a new report
by Grand View Research, Inc. The base of
population addicted to smoking is rapidly
increasing across the globe. This population
subset majorly includes teenagers and the
working population. Smoking-related mortality is
very high. The increasing desire to quit smoking
and the numerous health complications associated
with smoking serve as strong incentives for
companies to introduce novel smoking cessation
products, such as Revolymer, which has introduced
the next generation nicotine gums to help
smokers quit smoking. The launch of these
improved and innovative nicotine replacement
therapy products is to serve as a high impact
rendering driver for the growth of the smoking
cessation and nicotine de-addiction market. The
growing incidence of target diseases such as
chronic obstructive pulmonary disease (COPD),
asthma, cardiac diseases, and lung cancer, and
the increasing awareness pertaining to the
hazardous side-effects of smoking are the
factors expected to promote market expansion.
Educational institutions remain active in
organizing various
2

• campaigns and programs to spread information
  about the harmful effects and consequences of
  smoking so as to increase young population
  awareness.
• Browse Details of Report _at_
• http//www.grandviewresearch.com/industry-analysis
  /smoking-cessation-and-nicotine-de-addiction-produ
  cts- market
• Further key findings from the study suggest
• Nicotine Replacement Therapy (NRT) dominated the
  smoking cessation and de-nicotine addiction
  product market in 2015. Majorly used NRT
  products include nicotine chewing gums and the
  transdermal patches. Increased availability and
  the introduction of the ingestible nicotine
  products with different flavors are the factors
  responsible for its large market share.
• The e-cigarette segment is anticipated to grow at
  a CAGR of19.0 over the forecast period. The
  major factors responsible for the growth of the
  E-cigarette market include the introduction of
  second and third generation e-cigarettes, the
  availability of various flavored products, the
  presence of numerous vendors operating and
  selling e-cigarettes under different brand names.
• North America held a large market share of over
  35.0 in 2015 owing to the high awareness levels
  of nicotine de-addiction products with around
  90 of the U.S. population were identified as
  aware of e- cigarettes in 2015
• Asia Pacific is the fastest growing market. The
  registration of nicotine de-addiction products
  and e- cigarettes as well as the strengthening
  of the company distribution channels in
  countries, such as China, India, and Australia
  are expected to support the growth over the
  forecast period
• Some key players of this market are Pfizer, Inc.,
  Cipla Ltd., Novartis International AG,
  GlaxoSmithKline plc, Takeda pharmaceutical
  Company Ltd., McNeil AB, Revolymer plc, Imperial
  Tobacco Ltd., and VMR products, LLC
• The market players are making slow but steady
  progress in the e-cigarette market by focusing on
  the development, commercialization, and
  distribution of the FDA approved nicotine
  products. For instance, in 2014, Victory
  Electronic Cigarettes Corporation acquired Ten
  Motives Ltd. with an aim to expand their
  distribution channels and attain wider market
  coverage.

3
About Us Grand View Research, Inc. is a U.S.
based market research and consulting company,
registered in the State of California and
headquartered in San Francisco. The company
provides syndicated research reports, customized
research reports, and consulting services. To
help clients make informed business decisions,
the company offers market intelligence studies
ensuring relevant and fact-based research across
a range of industries including technology,
chemicals, materials, healthcare and
energy. Contact Sherry James Corporate Sales
Specialist, USA Grand View Research, Inc Phone
1-415- 349-0058 Toll Free 1-888- 202-9519 Email
sales_at_grandviewresearch.com For More Information
https//www.grandviewresearch.com